ClinicalTrials.gg
RecruitingNCT06404632Updated Aug 12, 2026

A Group Intervention for Promoting Health-related Habits (LEV-G)

An interventional study of Lev-g in Life Style, Health-Related Behavior and Disabilities Mental, sponsored by Region Stockholm. Recruiting at 1 site in Sweden. Open to participants aged 15 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-08-12.

Sponsored by Region Stockholm · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
15 Years to 80 Years
Sex
All
01

Study summary

Health-related habits influences mental and physical health. Still, treatment of health-related habits, which can help to remedy health problems, is often not done at all or very superficially. Multiple guidelines emphasize the importance of prioritizing health-related habits, but there is a lack of implemented models. To solve this, the investigators have developed a transdiagnostic, interprofessional material intended for several care settings. The Lev-g intervention is intended for groups. There is also an individual version of Lev that has its on registration in Clinical Trails.

Read the detailed description

Lev is a brief, transdiagnostic, interprofessional intervention targeting health-related habits that is intended for several care settings. The main population intended is individuals with neurodevelopmental disorders or parents or close relations to children with disabilities. This study will therefore be open for participants recruited from several types of healthcare services in Sweden.

Study 1: The feasibility trial investigates the following questions:

Completion: How many participants that started Lev completed the intervention? What were the reasons for not not completing Lev? How many sessions did the participants complete? Lev includes screening (Lev-s), three sessions + one booster session.

Level of acceptability: Was Lev perceived as creditable and satisfactory by healthcare workers and participants? Treatment credibility will be measured before Lev and after the last session for both participants and healthcare workers. Treatment satisfaction will be evaluated after each session and after the intervention is completed. Session evaluations will be done by both participants and healthcare workers.

Do the intervention lead to adverse events? To what extent were individual goals met?

02

Conditions studied

  • Life Style
  • Health-Related Behavior
  • Disabilities Mental
  • Disability Physical
  • Acceptability of Health Care
03

In context

Health Behavior

967 studies on the registry are indexed under Health Behavior; 165 are open to participants now.

This study's planned enrollment of 30 is below the median of 150 across 824 interventional studies indexed under Health Behavior.

Browse Health Behavior studies →

Lead sponsor

Region Stockholm is the lead sponsor of 121 studies on the registry; 69 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • both adults with and without disabilities recruited from different healthcare contexts.

Exclusion criteria

Exclusion Criteria:

  • Intellectual disability of the degree where the participant is not able to follow the protocol in Lev.

    • Insufficient command of the Swedish language/ unable to understand the content.
    • Severe psychiatric comorbidity that makes participation difficult (e.g. severe depression, severe suicidality, severe anxiety, ongoing psychosis, manic episode), other circumstances that could make participation hard (e.g. homelessness).
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Lev-g (group intervention)

    Lev-g includes three sessions + a booster session using psychoeducation, motivational interviewing, and applied behavioral analyses. Lev-g is done in groups to enable support and tips from others. There is no control condition. Only one arm to test feasibility.

    Behavioral: Lev-g

Interventions

  • BehavioralLev-g

    Lev-g includes three sessions + a booster session using psychoeducation, motivational interviewing, and applied behavioral analyses. Lev-g is done in groups to enable support and tips from others.

06

What researchers measure

Primary outcomes

  1. Completion rate participants

    How many of the participants that started using Lev (i.e., completing screening with Lev-s) completed Lev (i.e., completing, 3 out of 4 session)

    Time frame: within 3-4 months

Secondary outcomes

  1. Level of treatment credibility participants

    Was Lev perceived as creditable by participants using Treatment and Credibility Scale. Four items for credibility and one for expectation on a 10 point Likert scale where higher values indicate higher credibility.

    Time frame: Before and after taking part in Lev (after refers to completing the three sessions i.e, not including the booster session after three months). I.e within 6 weeks

  2. Level of treatment credibility healthcare workers

    Was Lev perceived as creditable by healthcare workers using Treatment and Credibility Scale . Four items for credibility and one for expectation on a 10 point Likert scale where higher values indicate higher credibility.

    Time frame: Before and after taking part in Lev (after refers to completing the three sessions i.e, not including the booster session after three months)I.e within 6 weeks

  3. Treatment satisfaction participants (individual sessions)

    Treatment satisfaction will be evaluated after session 1 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. After the meeting today, my knowledge of how I can change my lifestyle have increased. I will benefit from what we talked about during the meeting today The content of the meeting felt relevant based on my own experiences I understood the advice and strategies I was given that will help my change mine lifestyle habits I feel confident in how to use the advice and strategies I will use the advice and strategies I was listened to, the therapist understood my situation I was involved and helped to come up with suggestions for how I can reach my goals Is there something else you would like to add?

    Time frame: After completing the first session in Lev. An average of 1-2 weeks from baseline

  4. Treatment satisfaction participants (individual sessions)

    Treatment satisfaction will be evaluated after session 2 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. After the meeting today, my knowledge of how I can change my lifestyle have increased. I will benefit from what we talked about during the meeting today The content of the meeting felt relevant based on my own experiences I understood the advice and strategies I was given that will help my change mine lifestyle habits I feel confident in how to use the advice and strategies I will use the advice and strategies I was listened to, the therapist understood my situation I was involved and helped to come up with suggestions for how I can reach my goals Is there something else you would like to add?

    Time frame: After completing the second session in Lev. An average of 2-3 weeks from baseline

  5. Treatment satisfaction participants (individual sessions)

    Treatment satisfaction will be evaluated after session 3 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. After the meeting today, my knowledge of how I can change my lifestyle have increased. I will benefit from what we talked about during the meeting today The content of the meeting felt relevant based on my own experiences I understood the advice and strategies I was given that will help my change mine lifestyle habits I feel confident in how to use the advice and strategies I will use the advice and strategies I was listened to, the therapist understood my situation I was involved and helped to come up with suggestions for how I can reach my goals Is there something else you would like to add?

    Time frame: After completing the third session in Lev. An average of 3-4 weeks from baseline

  6. Treatment satisfaction participants (individual sessions)

    Treatment satisfaction will be evaluated after booster session using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. After the meeting today, my knowledge of how I can change my lifestyle have increased. I will benefit from what we talked about during the meeting today The content of the meeting felt relevant based on my own experiences I understood the advice and strategies I was given that will help my change mine lifestyle habits I feel confident in how to use the advice and strategies I will use the advice and strategies I was listened to, the therapist understood my situation I was involved and helped to come up with suggestions for how I can reach my goals Is there something else you would like to add?

    Time frame: After completing the booster session in Lev. An average of 3-4 month from baseline

  7. Treatment satisfaction participants (the three sessions)

    Treatment satisfaction will be evaluated after competing the three sessions using Patient Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. As a whole, the Lev has been clearly focused on how I can live healthier My knowledge of how I can have healthier habits has increased I can better deal with problems connected to my health-related habits I have had the opportunity to contribute opinions during the Lev I would consider participating in a similar interventions in the future The participants also rated the course as a whole following the school grading system ''Failed,'' ''Passed,'' ''Passed with distinction,'' and ''Passed with special

    Time frame: Directly after completing the last treatment module in LEV (approximately at 3-4 weeks from baseline)]

  8. Treatment satisfaction participants (the whole intervention including the booster session)

    Treatment satisfaction will be evaluated after competing the whole intervention using Patient Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. As a whole, the Lev has been clearly focused on how I can live healthier My knowledge of how I can have healthier habits has increased I can better deal with problems connected to my health-related habits I have had the opportunity to contribute opinions during the Lev I would consider participating in a similar interventions in the future The participants also rated the course as a whole following the school grading system ''Failed,'' ''Passed,'' ''Passed with distinction,'' and ''Passed with special

    Time frame: Directly after completing the last treatment module in LEV (approximately at 3-4 month from baseline)]

  9. Open answer questions regarding Treatment satisfaction measured by The Evaluation Questionnaire for participants

    The treatment satisfaction questionnaire also included open questions that will be analyses using a qualitative thematic approach including the following questions: I feel that participating in Lev helped me in these ways How could the Lev have been better? What could I have done differently myself? Is there anything else you would like to add? A qualitative, thematic analysis will be performed to identify more general themes. There is not a template or scale to extract the themes. One rater suggest categories based on the similarity of answers. Another rater organizes the answers in the suggested themes. To be considered a theme, there must be over 85% similarity between raters. I would consider participating in a similar interventions in the future The participants also rated the course as a whole following the school grading system ''Failed,'' ''Passed,'' ''Passed with distinction,'' and ''Passed with special

    Time frame: Directly after completing the third session in LEV (approximately at 3-4 weeks from baseline)]

  10. Open answer questions regarding Treatment satisfaction measured by The Evaluation Questionnaire for participants

    The treatment satisfaction questionnaire also included open questions that will be analyses using a qualitative thematic approach including the following questions: I feel that participating in Lev helped me in these ways How could the Lev have been better? What could I have done differently myself? Is there anything else you would like to add? A qualitative, thematic analysis will be performed to identify more general themes. There is not a template or scale to extract the themes. One rater suggest categories based on the similarity of answers. Another rater organizes the answers in the suggested themes. To be considered a theme, there must be over 85% similarity between raters. I would consider participating in a similar interventions in the future. The participants also rated the course as a whole following the school grading system ''Failed,'' ''Passed,'' ''Passed with distinction,'' and ''Passed with special

    Time frame: Directly after completing the booster session in LEV (approximately at 3-4 month from baseline)]

  11. Treatment satisfaction healthcare workers (individual sessions)

    Treatment satisfaction will be evaluated after session 1 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. The content of this session feels relevant The degree of difficulty in conveying the content of the session is at a reasonable level for me as a therapist Is there something else you would like to add?

    Time frame: After completing the first session in Lev. An average of 1-2 weeks from baseline

  12. Treatment satisfaction healthcare workers (individual sessions)

    Treatment satisfaction will be evaluated after session 2 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. The content of this session feels relevant The degree of difficulty in conveying the content of the session is at a reasonable level for me as a therapist Is there something else you would like to add?

    Time frame: After completing the first session in Lev. An average of 2-3 weeks from baseline

  13. Treatment satisfaction healthcare workers (individual sessions)

    Treatment satisfaction will be evaluated after session 3 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. The content of this session feels relevant The degree of difficulty in conveying the content of the session is at a reasonable level for me as a therapist Is there something else you would like to add?

    Time frame: After completing the first session in Lev. An average of 3-4 weeks from baseline

  14. Treatment satisfaction healthcare workers (individual sessions)

    Treatment satisfaction will be evaluated after the booster session using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction. The content of this session feels relevant The degree of difficulty in conveying the content of the session is at a reasonable level for me as a therapist Is there something else you would like to add?

    Time frame: After completing the first session in Lev. An average of 3-4 months from baseline

  15. Well-being before and after the intervention measures by The Evaluation Questionnaire

    ("How would you rate your well-being prior to the intervention?", "How would you rate your current well-being") at T1 and T2 on a scale 1-10 (1= very poor, 10= very good)

    Time frame: Directly after completing the third treatment module in LEV (approximately at 3-4 weeks)

  16. Well-being before and after the intervention measures by The Evaluation Questionnaire

    ("How would you rate your well-being prior to the intervention?", "How would you rate your current well-being") at T1 and T2 on a scale 1-10 (1= very poor, 10= very good)

    Time frame: Directly after completing the booster session module in LEV (approximately at 3-4 months)

  17. Adverse events after the intervention

    Adverse events will be defined as spontaneous oral complaints or instances when patients stated that they experienced negative or unwanted effects during the intervention period. Serious adverse events will be defined as events that involved hospital care/hospitalization, etc. due to the intervention.

    Time frame: During the intervention up to week approximately 3-4 months

  18. To what extent were individual goals met?

    The healthcare worker assesses to what extent the goals have been met using the goal attainment scale. 5 point scale where high vales indicate that goals have been reached to a higher extent.

    Time frame: Directly after completing the third treatment module in LEV (approximately at 3-4 weeks)

  19. To what extent were individual goals met?

    The healthcare worker assesses to what extent the goals have been met using the goal attainment scale. 5 point scale where high vales indicate that goals have been reached to a higher extent.

    Time frame: Directly after completing the booster session module in LEV (approximately at 3-4 months)

  20. Self-efficacy for promoting health behaviors for their children

    Participants are asked to assess self-efficacy for promoting health behaviors using the "Parental self-efficacy for healthy dietary and physical activity behaviors in preschool children (PDAP) including 24 items on a 0-10 point scale where high values indicate higher self-efficacy

    Time frame: Directly after completing the third session in LEV (approximately at 3-4 weeks)

  21. Self-efficacy for promoting health behaviors for their children

    Participants are asked to assess self-efficacy for promoting health behaviors using the "Parental self-efficacy for healthy dietary and physical activity behaviors in preschool children (PDAP) including 24 items on a 0-10 point scale where high values indicate higher self-efficacy

    Time frame: Directly after completing the booster session in LEV (approximately at 3-4 month)

  22. Do Lev lead to healthier habits?

    The Lev-s will be used to measure diet and physical activity before and after taking part in Lev. The scale includes 4 levels where higher levels indicate healthier habits.

    Time frame: Before and after taking part in Lev (after is after the third, 3-4 weeks, as wells as after the booster session, 3-4 month)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Douglas Sjöwall will be responsible for granting access to data only to researchers who are participating in the publications

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06404632
Lead sponsor
Region Stockholm
Collaborators
Karolinska Institutet, Promobilia Foundation
Responsible party
Douglas Sjowall (PhD, Associate professor, Region Stockholm) — Principal investigator
First posted
May 8, 2024
Start date
Apr 12, 2024
Primary completion
Feb 28, 2027 (estimated)
Completion
Feb 28, 2027 (estimated)
Last update
Aug 12, 2026

Study contacts

Douglas Sjöwall, PhD
Contact
douglas.sjowall@ki.se
+46 (0)739568658
Joakim Lavesson, Bachelor
Contact
joakim.lavesson@regionstockholm.se
+46 8 123 350 01
Douglas Sjöwall, PhD
principal investigator · Region Stockholm

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion